• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mol Ecol . Antigenic variation of SARS-CoV-2 in response to immune pressure

tetano

Editor, Senior Moderator
Mol Ecol


. 2020 Dec 2.
doi: 10.1111/mec.15730. Online ahead of print.
Antigenic variation of SARS-CoV-2 in response to immune pressure


Diego Forni[SUP] 1 [/SUP], Rachele Cagliani[SUP] 1 [/SUP], Chiara Pontremoli[SUP] 1 [/SUP], Alessandra Mozzi[SUP] 1 [/SUP], Uberto Pozzoli[SUP] 1 [/SUP], Mario Clerici[SUP] 2 3 [/SUP], Manuela Sironi[SUP] 1 [/SUP]



Affiliations

Abstract

Analysis of the bat viruses most closely related to SARS-CoV-2 indicated that the virus probably required limited adaptation to spread in humans. Nonetheless, since its introduction in human populations, SARS-CoV-2 must have been subject to the selective pressure imposed by the human immune system. We exploited the availability of a large number of high-quality SARS-CoV-2 genomes, as well as of validated epitope predictions, to show that B cell epitopes in the spike glycoprotein (S) and in the nucleocapsid protein (N) have higher diversity than nonepitope positions. Similar results were obtained for other human coronaviruses and for sarbecoviruses sampled in bats. Conversely, in the SARS-CoV-2 population, epitopes for CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells were not more variable than nonepitope positions. A significant reduction in epitope variability was instead observed for some of the most immunogenic proteins (S, N, ORF8 and ORF3a). Analysis over longer evolutionary time frames indicated that this effect is not due to differential constraints. These data indicate that SARS-CoV-2 evolves to elude the host humoral immune response, whereas recognition by T cells is not actively avoided by the virus. However, we also found a trend of lower diversity of T cell epitopes for common cold coronaviruses, indicating that epitope conservation per se is not directly linked to disease severity. We suggest that conservation serves to maintain epitopes that elicit tolerizing T cell responses or induce T cells with regulatory activity.

Keywords: B cell epitope; COVID‐19; SARS‐CoV‐2; T cell epitope; human coronavirus; sarbecovirus.
 
Back
Top Bottom